在阿尔茨海默氏病研究中,基于连接性的直角稀疏关节非负矩阵因子化的应用
Wei Kong1, Feifan Xu1, Shuaiqun Wang1
1College of Information Engineering, Shanghai Maritime University, Shanghai 201306, China.
Mathematical biosciences and engineering : MBE
|June 16, 2023
概括
这项研究引入了一种新的成像遗传学方法,OSJNMF-C,用于分析阿尔茨海默病 (AD) 数据. 该方法通过整合脑成像和遗传信息来提高诊断准确性,识别AD和轻度认知障碍 (MCI) 的潜在生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 医疗成像医学成像
- 计算生物学 计算生物学
背景情况:
- 图像遗传学对于早期阿尔茨海默病 (AD) 诊断至关重要,但整合先前的生物知识仍然具有挑战性.
- 了解AD的生物机制需要有效整合遗传变异和脑成像数据.
研究的目的:
- 提出一种基于连接性的新型直角稀疏关节非负矩阵分解 (OSJNMF-C) 方法.
- 整合结构磁共振成像 (sMRI),单核酸多态 (SNP) 和基因表达数据用于AD分析.
- 提高AD和轻度认知障碍 (MCI) 预测的准确性和生物解释性.
主要方法:
- 开发了OSJNMF-C,结合了相关性,稀疏性,直角约束和大脑连接信息.
- 将该方法应用于AD患者的结构性MRI,SNP和基因表达数据.
- 对竞争算法进行性能评估,重点关注准确性,收性和防噪能力.
主要成果:
- 与现有方法相比,OSJNMF-C显示出明显较小的错误和客观函数值.
- 该算法表现出强大的反噪声性能.
- 确定了潜在的AD/MCI生物标志物和显著的基因-大脑区域关联,如rs75277622和BCL7A.
结论:
- 拟议的OSJNMF-C方法有效地整合了多式联络数据,以改善AD/MCI分析.
- 鉴定的生物标志物表明对大脑功能和结构的潜在影响,促进AD/MCI预测.
- 这种方法为揭示AD背后的生物机制提供了一个有希望的途径.
相关概念视频
Alzheimer's Disease: Overview
532
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
532
Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K


